Literature DB >> 23791004

Management of patients with rectus sheath hematoma: Personal experience.

Antonino Buffone1, Guido Basile2, Mario Costanzo3, Massimiliano Veroux3, Lorenza Terranova3, Antonio Basile4, Valeriya Okatyeva3, Maria Teresa Cannizzaro5.   

Abstract

BACKGROUND/
PURPOSE: Rectus sheath hematoma (RSH) is a rare clinical entity. It can be mistaken for other intra-abdominal disorders, which can result in diagnostic and therapeutic difficulties. This study was undertaken to analyze the clinical presentation, diagnostic modalities, and management of patients affected with RSH.
METHODS: Between January 2008 and June 2011, eight patients (5 men and 3 women with a mean age of 53 years) with RSH were evaluated according to demographic characteristics, clinical and radiological findings, and methods of treatment.
RESULTS: Six patients developed RSH after anticoagulant therapy; one after local trauma, and one after laparoscopic intervention. Six patients were treated nonsurgically; one patient underwent embolization of the inferior epigastric artery and one underwent ligation of the bleeding vessel. The average hospital stay was 6 days. There were no mortality or thromboembolic complications.
CONCLUSION: RSH is a rare nonneoplastic entity that is usually associated with abdominal trauma and/or anticoagulant therapy. The gold standard for diagnosis is computed tomography, and ultrasonography can be used in follow-up. The treatment of choice is nonsurgical therapy because RSH is a self-limited condition. Surgical intervention should be reserved for cases with hemodynamic instability.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  abdominal pain; hematoma; rectus abdominal muscle; treatment

Mesh:

Substances:

Year:  2013        PMID: 23791004     DOI: 10.1016/j.jfma.2013.04.016

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  8 in total

1.  Rectus sheath hematoma: conservative, endovascular or surgical treatment? A single-center artificial neural network analysis.

Authors:  Cristian A Angeramo; Patricio Méndez; Eduardo P Eyheremendy; Francisco Schlottmann
Journal:  Eur J Trauma Emerg Surg       Date:  2022-01-15       Impact factor: 3.693

2.  Transarterial embolization with n-butyl cyanoacrylate for the treatment of abdominal wall hemorrhage.

Authors:  Tales Vieira Cavalcanti Albuquerque; Lucas Moretti Monsignore; Luis Henrique de Castro-Afonso; Jorge Elias-Junior; Valdair Francisco Muglia; Daniel Giansante Abud
Journal:  Diagn Interv Radiol       Date:  2020-05       Impact factor: 2.630

3.  A case report on rectus sheath hematoma in an intubated COVID-19 patient.

Authors:  Bhasyani Nagaretnam
Journal:  Turk J Emerg Med       Date:  2022-04-11

4.  An Uncommon Presentation of Spontaneous Rectus Sheath Hematoma with Acute Kidney Injury due to Obstructive Uropathy and Prerenal Azotemia.

Authors:  Eleni Paschou; Eleni Gavriilaki; Asterios Kalaitzoglou; Maria Mourounoglou; Nikolaos Sabanis
Journal:  Case Rep Emerg Med       Date:  2014-07-13

Review 5.  A Proposed Algorithm on the Modern Management of Rectus Sheath Hematoma: A Literature Review.

Authors:  En-Dien Liao; Yana Puckett
Journal:  Cureus       Date:  2021-11-29

6.  Efficacy of Percutaneous Transarterial Embolization in Patients with Spontaneous Abdominal Wall Hematoma and Comparison between Blind and Targeted Embolization Approaches.

Authors:  Stefano Di Pietro; Francesco Tiralongo; Carla Maria Desiderio; Francesco Vacirca; Stefano Palmucci; Francesco Giurazza; Massimo Venturini; Antonio Basile
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

7.  Spontaneous rectus sheath hematoma in the elderly: an unusual case and update on proper management.

Authors:  George Galyfos; Georgios Karantzikos; Konstantinos Palogos; Argiri Sianou; Konstantinos Filis; Nikolaos Kavouras
Journal:  Case Rep Emerg Med       Date:  2014-03-11

8.  Comparison of the Different Treatment Strategies for Patients with Rectus Sheath Haematoma.

Authors:  Audrius Gradauskas; Linas Venclauskas; Matas Pažusis; Andrius Karpavičius; Almantas Maleckas
Journal:  Medicina (Kaunas)       Date:  2018-05-30       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.